Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 20/20 | 1.00 |
| ▸ | CYP11B1 | P15538 | 15/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20338212 | 1.00 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20340176 | 0.87 | CYP11B2 (0.77) | CYP11B2CYP11B1 | |
| SCHEMBL30657527 | 0.86 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20338229 | 0.86 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL18791093 | 0.80 | CYP11B2 (0.66) | CYP11B2CYP11B1 | |
| SCHEMBL20338165 | 0.79 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20338211 | 0.77 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20338335 | 0.73 | CYP11B2 (0.78) | CYP11B2CYP11B1 | |
| SCHEMBL30657550 | 0.73 | CYP11B2 (0.80) | CYP11B2CYP11B1 | |
| SCHEMBL20338230 | 0.73 | CYP11B2 (0.80) | CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458642-B2 | Metalloenzyme inhibitor compounds | CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) | 2025-11-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458642-B2 | Metalloenzyme inhibitor compounds | CYP11B2, CYP11B1, HSD11B2 | CYP11B2 1/4885CYP11B1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.